Skip to main content

Dentsply Sirona Names Daniel Scavilla CEO to Accelerate Strategic Transformation and Innovation

Submitted by fairsonline´s … on
Dentsply Sirona Names Daniel Scavilla CEO to Accelerate Strategic Transformation and Innovation

SHERIDAN, WYOMING – July 29, 2025 – Dentsply Sirona has appointed veteran medtech executive Daniel Scavilla as President and Chief Executive Officer, effective August 1, 2025, in a leadership move designed to accelerate its ongoing transformation, deepen innovation, and unlock new commercial opportunities across the global dental market.

A leadership shift with proven operational impact

Scavilla joins the executive ranks from within Dentsply Sirona’s Board of Directors, where he has served since February 2025. His appointment follows the planned departure of outgoing CEO Simon Campion, who concludes his three-year tenure on July 31. With over 30 years of experience spanning Johnson & Johnson and Globus Medical, Scavilla brings a track record of leading major integrations, scaling commercial infrastructure, and advancing market leadership positions.

At Globus Medical, he was instrumental in orchestrating the $3 billion all-stock acquisition of NuVasive, creating the world’s second-largest spine technology company. His operational footprint extends across M&A, commercial growth, and advanced manufacturing—a combination seen as highly strategic for Dentsply Sirona’s next phase.

Focus on value creation and dental market transformation

In his first statement as incoming CEO, Scavilla emphasized both continuity and ambition: “Dentsply Sirona is a company that I have admired for its trusted brands, and since joining the Board in February, I have gained an even deeper appreciation for the enormous potential of our business, people and products. The Board and I are aligned in our belief that, while our ongoing transformation is yielding results, there is more we can do to drive improved commercial, operational and financial performance across the organization. As I step into the CEO role, I look forward to working with the team to continue the Company’s transformation and drive sustained profitable growth and enhance value for all stakeholders.”

The move comes amid increasing demand for digitized, efficient, and patient-centric dental solutions. The global dental technology market—projected to grow at over 7% CAGR through 2030—is pushing manufacturers toward faster innovation cycles, connected care platforms, and AI-driven diagnostics. Dentsply Sirona’s refreshed leadership is expected to accelerate its ability to compete in this evolving landscape.

Strategic operational blueprint from the spine sector

Scavilla’s leadership style is rooted in scalable operational models. During his tenure at Globus Medical, he launched the Orthopedics and Trauma business, expanded global distribution, and helped secure the top market position in sterilization technology while at Johnson & Johnson’s Advanced Sterilization Products division.

For Dentsply Sirona, which operates across consumables, equipment, and digital workflows, such cross-functional experience will be vital in optimizing both its product portfolio and cost structure. His deep knowledge of clinical informatics and product lifecycle integration is also expected to enhance dental workflow platforms, a key growth area as practices invest in end-to-end digital solutions.

Board confidence in performance-led transformation

The company’s Board of Directors underscored the strategic alignment of Scavilla’s appointment. Gregory T. Lucier, Chairman of the Board, stated: “Dan’s appointment as CEO underscores the Board’s strong and unwavering commitment to delivering enhanced value to shareholders and positioning Dentsply Sirona for future success. Dan is a seasoned healthcare veteran, and we’re confident that his three decades of executive leadership experience and disciplined focus on commercial growth, product innovation and financial and operational excellence make him well-suited to lead the Company into its next chapter.”

Implications for providers and global practices

With Scavilla at the helm, Dentsply Sirona is expected to double down on clinical productivity tools, practice-ready digital ecosystems, and global market expansion. For dental providers, this could translate into:

  • Greater access to integrated diagnostics and imaging platforms
  • Enhanced chairside workflow solutions for improved efficiency
  • Broader training and clinical support for adopting digital dental systems
  • Stronger alignment with value-based care and reimbursement models

These improvements are not only likely to benefit clinicians and practices but also align Dentsply Sirona more closely with evolving patient expectations and regulatory trends around interoperability and connected health technologies.

Looking ahead: momentum and market readiness

As Scavilla assumes leadership, he is expected to resign from the board of Globus Medical but will remain on the Dentsply Sirona Board. His focus will now turn to navigating global market shifts, sustaining innovation in core business lines, and driving shareholder value.

For investors, stakeholders, and healthcare providers alike, Dentsply Sirona’s leadership transition signals an assertive pivot toward long-term performance, deeper product integration, and stronger clinical outcomes.

Learn more at www.dentsplysirona.com.